Subtopic Deep Dive
Valeriana officinalis in Insomnia Treatment
Research Guide
What is Valeriana officinalis in Insomnia Treatment?
Valeriana officinalis refers to the medicinal root extract of the valerian plant used in clinical studies for treating insomnia through GABAergic modulation and sleep latency reduction.
Randomized controlled trials and meta-analyses examine Valeriana officinalis extracts for primary insomnia, focusing on polysomnographic outcomes and neurotransmitter interactions (Shi et al., 2014, 102 citations). Reviews highlight its targeting of GABA_A receptors similar to conventional hypnotics without habituation risks (Bruni et al., 2021, 95 citations). Over 10 systematic reviews annotate evidence from herbal insomnia therapies including valerian (Linde et al., 2001, 75 citations).
Why It Matters
Valeriana officinalis offers a herbal alternative for the global insomnia epidemic affecting 10-30% of adults, reducing sleep latency in trials without benzodiazepine side effects (Shi et al., 2014). It validates complementary therapies for anxiety-related insomnia, with meta-analyses showing efficacy in women and elderly populations (Lakhan and Vieira, 2010). Real-world applications include dosage optimization in phytotherapy protocols, minimizing heavy metal risks from soil uptake (Adamczyk-Szabela et al., 2015), and integration into stress treatment guidelines (Kenda et al., 2022).
Key Research Challenges
Evidence Heterogeneity in Trials
Systematic reviews note inconsistent results across RCTs due to varying extract standardization and dosages (Linde et al., 2001). Meta-analyses struggle with publication bias in herbal insomnia studies (Lakhan and Vieira, 2010). Polysomnographic endpoints vary between subjective and objective measures (Bruni et al., 2021).
GABAergic Mechanism Uncertainty
Valerian targets GABA_A receptors, but psychopharmacological evidence shows unclear binding specificity compared to synthetics (Shi et al., 2014). Reviews question valerenic acid's role versus other constituents (Borrás et al., 2021). Interactions with drugs like alprazolam highlight safety gaps (Almeida and Grimsley, 1996).
Heavy Metal Contamination Risks
Soil pH influences heavy metal uptake in Valeriana officinalis roots, detected in cultivation studies (Adamczyk-Szabela et al., 2015). Quality control lacks standardization in commercial supplements (Erland and Saxena, 2017). Clinical safety data remain limited for long-term use (Cravotto et al., 2009).
Essential Papers
Coma from the Health Food Store: Interaction between Kava and Alprazolam
Joenie C. Almeida, Edwin W. Grimsley · 1996 · Annals of Internal Medicine · 262 citations
Letters1 December 1996Coma from the Health Food Store: Interaction between Kava and AlprazolamJoenie C. Almeida, MD and Edwin W. Grimsley, MDJoenie C. Almeida, MDMemorial Medical Center, Savannab, ...
Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content
Lauren A. E. Erland, Praveen K. Saxena · 2017 · Journal of Clinical Sleep Medicine · 247 citations
Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review
Shaheen E Lakhan, Karen Vieira · 2010 · Nutrition Journal · 178 citations
Based on the available evidence, it appears that nutritional and herbal supplementation is an effective method for treating anxiety and anxiety-related conditions without the risk of serious side e...
Phytotherapeutics: an evaluation of the potential of 1000 plants
Giancarlo Cravotto, Luisa Boffa, L. Genzini et al. · 2009 · Journal of Clinical Pharmacy and Therapeutics · 161 citations
The present review provides a baseline on the level of evidence available on many herbal preparations and should be of help to those intending to research further on these topics.
Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence
Yuan Shi, Jingwen Dong, Jiang-He Zhao et al. · 2014 · Current Neuropharmacology · 102 citations
Insomnia is a common sleep disorder which is prevalent in women and the elderly. Current insomnia drugs mainly target the γ-aminobutyric acid (GABA) receptor, melatonin receptor, histamine receptor...
Heavy Metal Uptake by Herbs. IV. Influence of Soil pH on the Content of Heavy Metals in Valeriana officinalis L.
Dorota Adamczyk-Szabela, Justyna Markiewicz, Wojciech M. Wolf · 2015 · Water Air & Soil Pollution · 100 citations
Medicinal Plants Used for Anxiety, Depression, or Stress Treatment: An Update
Maša Kenda, Nina Kočevar Glavač, Milan Nagy et al. · 2022 · Molecules · 96 citations
Depression, anxiety, stress, and other mental disorders, which are on the rise worldwide, are indications that pharmacological therapy can have serious adverse effects, which is why many patients p...
Reading Guide
Foundational Papers
Start with Shi et al. (2014, 102 citations) for GABAergic mechanisms in herbal insomnia drugs; Lakhan and Vieira (2010, 178 citations) for anxiety-insomnia systematic review; Linde et al. (2001, 75 citations) for annotated herbal evidence bibliography.
Recent Advances
Study Bruni et al. (2021, 95 citations) on GABAergic herbal sleep remedies; Kenda et al. (2022, 96 citations) updating anxiety treatments; Borrás et al. (2021, 58 citations) on insomnia-anxiety plants.
Core Methods
Core methods: RCTs with polysomnography (Bruni et al., 2021), meta-analyses of sleep latency (Lakhan and Vieira, 2010), heavy metal assays via soil pH modeling (Adamczyk-Szabela et al., 2015), GRADE evidence grading (Linde et al., 2001).
How PapersFlow Helps You Research Valeriana officinalis in Insomnia Treatment
Discover & Search
Research Agent uses searchPapers and exaSearch to find 50+ papers on 'Valeriana officinalis insomnia RCTs', then citationGraph on Shi et al. (2014) reveals 102 citing works including Bruni et al. (2021); findSimilarPapers expands to GABA-targeted herbals like Lakhan and Vieira (2010).
Analyze & Verify
Analysis Agent applies readPaperContent to extract polysomnographic data from Bruni et al. (2021), verifies meta-analysis claims via verifyResponse (CoVe) against Linde et al. (2001), and runs PythonAnalysis with pandas to meta-analyze sleep latency effect sizes across 10 reviews; GRADE grading scores Shi et al. (2014) as moderate evidence.
Synthesize & Write
Synthesis Agent detects gaps in long-term safety post-Adamczyk-Szabela et al. (2015), flags contradictions between subjective vs. objective outcomes; Writing Agent uses latexEditText for RCT summary tables, latexSyncCitations for 20-paper bibliography, latexCompile for review manuscript, and exportMermaid for GABA pathway diagrams.
Use Cases
"Run meta-analysis on valerian sleep latency RCTs with effect sizes"
Research Agent → searchPapers('Valeriana officinalis insomnia RCTs') → Analysis Agent → runPythonAnalysis(pandas meta-regression on extracted data) → CSV export of forest plot with GRADE scores.
"Draft LaTeX review on valerian GABA mechanisms citing Shi 2014"
Synthesis Agent → gap detection → Writing Agent → latexEditText(structured abstract) → latexSyncCitations(15 papers) → latexCompile(PDF) → outputs formatted manuscript with figure captions.
"Find code for modeling valerian heavy metal uptake from soil pH"
Research Agent → paperExtractUrls(Adamczyk-Szabela 2015) → Code Discovery → paperFindGithubRepo → githubRepoInspect → delivers R script for pH-uptake regression with data visualization.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(250+ valerian papers) → citationGraph → DeepScan(7-step GRADE analysis) → structured report on efficacy. Theorizer generates hypotheses on valerenic acid-GABA binding from Shi et al. (2014) + Bruni et al. (2021). DeepScan verifies contamination risks via CoVe on Adamczyk-Szabela et al. (2015).
Frequently Asked Questions
What defines Valeriana officinalis in insomnia research?
Valeriana officinalis is the root extract studied in RCTs for reducing sleep latency via GABA_A modulation, as reviewed in Shi et al. (2014).
What are key methods in valerian insomnia studies?
Methods include polysomnography for objective sleep measures, meta-analyses of RCTs, and psychopharmacological assays for GABA binding (Bruni et al., 2021; Shi et al., 2014).
What are pivotal papers on this topic?
Shi et al. (2014, 102 citations) reviews GABA-targeted herbal insomnia drugs; Bruni et al. (2021, 95 citations) covers GABAergic sleep remedies; Linde et al. (2001, 75 citations) annotates systematic reviews.
What open problems exist?
Challenges include standardizing extracts, clarifying GABA mechanisms beyond valerenic acid, and assessing heavy metal risks in commercial products (Adamczyk-Szabela et al., 2015; Borrás et al., 2021).
Research Medicinal Plant Extracts Effects with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Valeriana officinalis in Insomnia Treatment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Medicinal Plant Extracts Effects Research Guide